Oklahoma Medical Research Foundation scientists have discovered a potential new approach to treating sickle cell disease, the most common inherited blood disorder in the U.S. Their work could someday lead to a new drug to treat the active pain crises that accompany the disease or perhaps prevent them all together. “Although sickle cell was identified […]
pain crises
OMRF study finds potential treatment for sickle cell disease complication
Experimental drug may reduce length, severity of attacks
A Sickle Cell Milestone
New drug with OMRF roots reduces pain in sickle cell disease.
FDA approves new sickle cell drug with Oklahoma roots
Adakveo significantly reduces pain crises in sickle cell patients.